Steven M Friedman

Title: Innovations and Contributions of Steven M. Friedman

Introduction

Steven M. Friedman is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of cancer treatment, particularly in relation to breast cancer. With a total of three patents to his name, his work focuses on innovative methods and compositions that aim to improve therapeutic outcomes.

Latest Patents

Friedman's latest patents include compositions, methods, and kits relating to HER-2 cleavage. These inventions are based on the ADAM-mediated cleavage of Her-2, which plays a crucial role in cancer treatment. His work highlights the potential for modulating this cleavage to treat breast cancer effectively. Additionally, he has identified novel variants of ADAM15, designated as ADAM15 variant 1 and ADAM15 variant 2. These variants are now isolated and hold promise for further research and application in cancer therapies.

Career Highlights

Throughout his career, Steven M. Friedman has worked with prominent companies such as Incyte Corporation and Incyte Holdings Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Friedman has collaborated with notable colleagues, including Peggy Ann Scherle and Krishna Vaddi. These partnerships have likely enhanced his research and development efforts in the realm of cancer treatment.

Conclusion

Steven M. Friedman is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.